0399.HK

Innovative Pharmaceutical Biotech Limited [0399.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0399.HK Stock Summary

In the News

0399.HK Financial details

Company Rating
Sell
Market Cap
346.36M
Income
95.48M
Revenue
11.5M
Book val./share
-0.41
Cash/share
0
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
29 Nov 2023
P/E
-1.24
Forward P/E
-
PEG
0.13
P/S
42.97
P/B
-0.38
P/C
-
P/FCF
-19.67
Quick Ratio
-
Current Ratio
0.01
Debt / Equity
-1.66
LT Debt / Equity
2.02
-
-
EPS (TTM)
0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-200%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.14%
Revenue last 5Y
-15.36%
Revenue Q/Q
100%
EPS Q/Q
974.38%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
37%
ROC
-0.09%
Gross Margin
11%
Oper. Margin
-256%
Profit Margin
-3043%
Payout
-
Shs Outstand
1.72B
Shs Float
1.29B
-
-
-
-
Target Price
-
52W Range
0.19-0.37
52W High
-
52W Low
-
RSI
45
Rel Volume
-
Avg Volume
69.54K
Volume
100
Perf Week
-1.48%
Perf Month
-0.99%
Perf Quarter
-
Perf Half Y
-16.67%
-
-
-
-
Beta
-0.123
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.2
Change
0.5%

0399.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.010.010.010.010.01
Net income per share
-0.18-0.28-0.270.17-0.17
Operating cash flow per share
-0.02-0.02-0.02-0.01-0.01
Free cash flow per share
-0.02-0.02-0.02-0.01-0.01
Cash per share
0.010.020.0100
Book value per share
-0.05-0.27-0.41-0.31-0.54
Tangible book value per share
-0.4-0.55-0.69-0.56-0.84
Share holders equity per share
-0.05-0.27-0.41-0.31-0.54
Interest debt per share
0.570.640.810.650.97
Market cap
592.86M373.33M364.5M260.78M304.55M
Enterprise value
1.29B1.14B1.35B1.2B1.49B
P/E ratio
-2.28-0.92-0.920.88-1.24
Price to sales ratio
31.8925.612423.437.72
POCF ratio
-20.1-10.31-14.58-21.14-17.26
PFCF ratio
-20.1-10.31-14.58-21.14-17.26
P/B Ratio
-7.91-0.96-0.61-0.47-0.38
PTB ratio
-7.91-0.96-0.61-0.47-0.38
EV to sales
69.1578.2188.68107.54185.01
Enterprise value over EBITDA
-111.33-46.03-70.77-53.93-79.38
EV to operating cash flow
-43.58-31.48-53.87-97.17-84.69
EV to free cash flow
-43.58-31.48-53.87-97.17-84.69
Earnings yield
-0.44-1.09-1.091.14-0.81
Free cash flow yield
-0.05-0.1-0.07-0.05-0.06
Debt to equity
-9.47-2.02-1.67-1.71-1.5
Debt to assets
0.450.560.710.680.86
Net debt to EBITDA
-59.98-30.96-51.62-42.2-63.2
Current ratio
1.370.60.040.190.01
Interest coverage
-0.09-0.18-0.11-0.13-0.09
Income quality
0.110.160.12-0.340.07
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.441.551.111.552.11
Research and developement to revenue
0.10.780.40.740.59
Intangibles to total assets
0.870.970.980.980.99
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.451.291.571.091.43
ROIC
-0.03-0.12-0.1-0.5-0.05
Return on tangible assets
-1.27-8.93-13.213.62-22.7
Graham Net
-0.51-0.56-0.7-0.56-0.85
Working capital
12.14M-28.35M-771.87M-80.82M-1.14B
Tangible asset value
-578.41M-805.45M-1.01B-977.96M-1.23B
Net current asset value
-739.4M-808.92M-1.02B-980.78M-1.23B
Invested capital
-9.47-2.02-1.67-1.71-1.5
Average receivables
10.59M18.39M15.47M12.41M7.96M
Average payables
15.81M15.73M7.87M6.82M6.09M
Average inventory
00.5110.5
Days sales outstanding
415.8390.74368.22311.26289.79
Days payables outstanding
459.75288.76145.08294.9203.41
Days of inventory on hand
00000
Receivables turnover
0.880.930.991.171.26
Payables turnover
0.791.262.521.241.79
Inventory turnover
012.96M13.78M10.09M0
ROE
3.471.040.66-0.540.31
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.08-0.04-0.090.010.13
Operating cash flow per share
0-0.01-0.0100
Free cash flow per share
0-0.01-0.0100
Cash per share
00000
Book value per share
-0.45-0.54-0.54-0.08-0.41
Tangible book value per share
-0.75-0.84-0.84-0.13-0.71
Share holders equity per share
-0.45-0.54-0.54-0.08-0.41
Interest debt per share
0.80.070.90.080.77
Market cap
308.94M292.84M304.55M1.6B349.94M
Enterprise value
1.36B291.51M1.49B1.6B1.34B
P/E ratio
-0.67-1.13-0.594.140.45
Price to sales ratio
74.66148.7677.36859.793.89
POCF ratio
-108.1-39.62-20.6-731.86-79.93
PFCF ratio
-108.1-39.62-20.6-731.86-79.93
P/B Ratio
-0.46-0.37-0.38-2.66-0.58
PTB ratio
-0.46-0.37-0.38-2.66-0.58
EV to sales
329.28148.09379.46859.24360.85
Enterprise value over EBITDA
-201.35-47.95-121.63-607.49-246.36
EV to operating cash flow
-476.75-39.44-101.07-731.47-307.19
EV to free cash flow
-476.75-39.44-101.07-731.47-307.19
Earnings yield
-0.37-0.22-0.430.060.55
Free cash flow yield
-0.01-0.03-0.050-0.01
Debt to equity
-1.59-0.12-1.5-1.12-1.66
Debt to assets
0.760.070.860.490.72
Net debt to EBITDA
-155.70.22-96.830.33-182.26
Current ratio
0.020.010.010.020.02
Interest coverage
-0.070-0.110-0.05
Income quality
0.020.110.11-0.02-0.02
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.82.651.331.690.84
Research and developement to revenue
0.360.830.830.080.08
Intangibles to total assets
0.990.990.990.990.99
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.90.741.040.141.11
ROIC
-0.020.01-0.03-0.04-0.02
Return on tangible assets
-6.36-6.01-12.0110.7721.53
Graham Net
-0.76-0.85-0.85-0.13-0.71
Working capital
-808.1M-1.14B-1.14B-369.17M-369.17M
Tangible asset value
-1.1B-1.23B-1.23B-1.04B-1.04B
Net current asset value
-1.1B-1.23B-1.23B-1.04B-1.04B
Invested capital
-1.59-0.12-1.5-1.12-1.66
Average receivables
07.71M6.29M6M5.59M
Average payables
05.99M4.02M3.77M3.52M
Average inventory
0-4.63M000
Days sales outstanding
201.21281.96146.56270.07135.04
Days payables outstanding
192.57206.85103.42189.394.65
Days of inventory on hand
-2240000
Receivables turnover
0.450.320.610.330.67
Payables turnover
0.470.440.870.480.95
Inventory turnover
-0.40000
ROE
0.170.080.16-0.16-0.32
Capex per share
00000

0399.HK Frequently Asked Questions

What is Innovative Pharmaceutical Biotech Limited stock symbol ?

Innovative Pharmaceutical Biotech Limited is a HK stock and trading under the symbol 0399.HK

What is Innovative Pharmaceutical Biotech Limited stock quote today ?

Innovative Pharmaceutical Biotech Limited stock price is $0.2 today.

Is Innovative Pharmaceutical Biotech Limited stock public?

Yes, Innovative Pharmaceutical Biotech Limited is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range
Similar Market Cap